Skip to content

"Investigation of the effect of dexmedetomidine infusion versus opioids on pain control, nausea, and vomiting after surgery.

Investigation of the effect of dexmedetomidine infusion versus opioids on pain control, nausea, and vomiting after surgery.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220429054694N2
Enrollment
170
Registered
2024-12-08
Start date
2024-12-25
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Investigating the effect of dexmedetomidine infusion compared to narcotics in controlling postoperative pain. Condition 2: Investigating the effect of dexmedetomidine infusion compared to narcotics in controlling postoperative nausea and vomiting. Upper abdominal pain, unspecified Vomiting following gastrointestinal surgery

Interventions

Intervention 1: Intervention group: Patients are given dexmedetomidine infusion at a dose of 1 µg/kg 10 minutes before the induction, and the induction, like the control group, includes midazolam, pro

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Elective inguinal hernia surger Classified as American Society of Anesthesiologists (ASA) 1 and 2

Exclusion criteria

Exclusion criteria: Allergic reaction to drugs Severe hemodynamic changes during surgery Complex surgery Patients taking drugs affecting QT interval Patients with myopathy and neuropathy. Patients with drug abuse Patients with chronic analgesic use

Design outcomes

Primary

MeasureTime frame
The pain level of the patients during the recovery period up to 24 hours after the operation is checked at 2, 4, 6, 12 and 24 hours. The amount of pain is based on the Visual Analogue Scale, where the lowest amount of pain is scored as zero and the highest amount of pain is scored as 10. The checklists prepared by the evaluator, who is blinded to the study, are performed at 2, 4, 12, and 24 hours. Timepoint: The amount of pain of patients in recovery up to 24 hours after the operation is checked at 2, 4, 6, 12 and 24 hours. Method of measurement: The amount of pain is based on the Visual Analogue Scale, where the lowest amount of pain is scored as 0 and the highest amount of pain is scored as 10.;The rate of nausea and vomiting of patients in recovery up to 24 hours after the operation is checked at 2, 4, 6, 12 and 24 hours. The scoring of nausea and vomiting is 4 points. (score 1 is no nausea and vomiting, score 2 is nausea without vomiting, score 3 is less than two episodes of vomiting, and score 4 is severe vomiting more than 2 episodes). It is done at 2, 4, 12 and 24 hours. Timepoint: The rate of nausea and vomiting of patients in recovery up to 24 hours after the operation is checked at 2, 4, 6, 12 and 24 hours. Method of measurement: The scoring of nausea and vomiting is 4 points. (score 1 is no nausea and vomiting, score 2 is nausea without vomiting, score 3 is less than two episodes of vomiting, and score 4 is severe vomiting more than 2 episodes).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Alipour

Mashhad University of Medical Sciences

alipourm@mums.ac.ir+98 51 3858 3878

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026